What ART Fertility Clinics does

ART Fertility Clinics is a specialty healthcare provider operating a network of fertility and IVF clinics across the United Arab Emirates and Saudi Arabia, founded in 2015 in Abu Dhabi. The company delivers a comprehensive suite of assisted reproductive technology (ART) services, including in vitro fertilization (IVF), intra-cytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), fertility preservation (egg, embryo, and sperm cryopreservation), and advanced male factor infertility treatments such as micro-TESE and PESA. A core technical differentiator is its in-house ART Genomics facility, which provides comprehensive preimplantation genetic testing (PGT-A, PGT-M, PGT-SR), endometrial receptivity analysis (ERA), endometrial microbiota analysis (EMMA/ALICE), chromosomal karyotyping, and sperm DNA fragmentation testing, paired with time-lapse embryo incubators for continuous embryo monitoring.

The business operates a direct-to-patient, sales-led model, with revenue generated through professional services delivered at five clinic locations (Abu Dhabi Marina Village, Al Ain, Dubai Jumeirah, Dubai Healthcare City, and Al Khobar, Saudi Arabia) supplemented by an international patient program serving patients from across the GCC and beyond. Pricing is quote-based and not publicly disclosed, with cryostorage contracts offering 5-year storage and annual renewals. The company employs a multilingual medical team of reproductive medicine specialists and PhD-level scientific directors, marketing through content-driven digital channels, social media, and research publications.

ART Fertility was acquired by Gulf Capital in 2020 and scaled from a UAE-focused operator into a 15-clinic regional platform, quadrupling the Middle East bottom line during ownership. In November 2025, IVI RMA Global (backed by KKR) acquired the Middle East operations (four clinics) for approximately $450 million, establishing the Middle East as IVI RMA Global's fifth geographic market. Gulf Capital retained 11 clinics in India. The company is now a private operating subsidiary of IVI RMA Global, the world's largest assisted reproduction group.

Name

ART Fertility Clinics

Legal name

ART Fertility Clinic LLC

Website

https://artfertilityclinics.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

251–500 employees

Short description

ART Fertility Clinics is a UAE-based specialty healthcare provider operating fertility and IVF clinics across the UAE and Saudi Arabia, delivering assisted reproduction services including IVF, ICSI, fertility preservation, and in-house genomic testing to couples and individuals seeking fertility treatment, now part of IVI RMA Global.

Ownership category

akta.pro rank

Headquarters

HQ city

Abu Dhabi

HQ country

United Arab Emirates

HQ region

Middle East

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Fertility Healthcare Services: Revenue generated from providing fertility treatments and healthcare services including IVF cycles, ICSI, IUI, diagnostic procedures, genetic testing, fertility preservation, and consultations. Services are delivered directly to patients at clinic locations with pricing quote-based and not publicly disclosed.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels9 records

Core offering

ART Fertility Clinics operates a network of fertility and IVF centers providing assisted reproduction treatments including IVF, ICSI, IUI, fertility preservation (egg, embryo, and sperm cryopreservation), and advanced genomic diagnostic services through an in-house ART Genomics facility. Services are delivered directly to patients across clinic locations in the UAE and Saudi Arabia, with personalized treatment plans determined after clinical consultation.

Product overview

ART Fertility Clinics operates as a network of fertility and IVF centers providing a comprehensive suite of assisted reproduction treatments. The core offerings include IVF, IUI, and ICSI treatments, complemented by an in-house genetics facility called ART Genomics that provides advanced genomic services including PGT-A, PGT-M, and PGT-SR testing. The company offers fertility preservation services (egg freezing, embryo freezing, sperm cryopreservation), diagnostic services for male and female infertility, and specialized surgical procedures such as micro TESE and PESA. Additional services include time-lapse incubator technology for embryo monitoring, endometrial receptivity analysis (ERA), and gender selection/family balancing through PGT-A testing. The platform also provides online fertility calculators and educational resources through its web stories and blog content.

Differentiator

Problem solved

Functional benefit

Brands

• ART Genomics: An in-house genetics and genomics facility providing diagnostic depth including preimplantation genetic testing (PGT-A, PGT-M, PGT-SR), chromosomal karyotyping, endometrial microbiota analysis (EMMA/ALICE), sperm aneuploidy screening, and sperm DNA fragmentation testing.

Products and services

• In Vitro Fertilization (IVF) Primary assisted reproduction treatment involving egg retrieval, laboratory fertilization, and embryo transfer to achieve pregnancy, offered to couples and individuals experiencing infertility.
• Intra-Cytoplasmic Sperm Injection (ICSI) Specialized IVF technique in which a single sperm is directly injected into an egg to improve fertilization chances, particularly indicated for male factor infertility.
• Intra Uterine Insemination (IUI) Fertility treatment in which prepared sperm is placed directly into the uterus during ovulation to increase fertilization chances, offered to couples experiencing infertility.
• ART Genomics In-house genetics and genomics facility providing comprehensive diagnostic services including PGT-A, PGT-M, PGT-SR, chromosomal karyotyping, endometrial microbiota analysis, and sperm DNA fragmentation testing for fertility patients.
• Preimplantation Genetic Testing for Aneuploidy (PGT-A) Genetic screening test that analyzes embryos for chromosomal abnormalities (aneuploidy) before implantation to improve IVF success rates, offered to couples undergoing IVF treatment.
• Preimplantation Genetic Testing for Monogenic disorders (PGT-M) Genetic test detecting single-gene (monogenic) disorders in embryos to prevent transmission of hereditary conditions to offspring, offered to couples with known genetic risk.
• Preimplantation Genetic Testing for Structural Rearrangements (PGT-SR) Genetic screening for embryos carrying chromosomal structural rearrangements such as translocations or inversions, offered to couples carrying such rearrangements.
• Egg Freezing Fertility preservation service allowing women to cryopreserve and store eggs for future family planning, including women delaying parenthood and those facing medical treatments such as chemotherapy.
• Embryo Freezing Cryopreservation service for storing embryos for future IVF cycles or family planning purposes, offered to couples and individuals with surplus embryos from IVF.
• Sperm Cryopreservation
• Endometrial Receptivity Analysis (ERA) Diagnostic test determining the optimal timing for embryo transfer by analyzing endometrial lining receptivity, used for women with recurrent implantation failure.
• In Vitro Maturation (IVM) Fertility treatment in which eggs are retrieved and matured in the laboratory before fertilization, offered as an alternative to standard IVF stimulation protocols.
• Microsurgical Testicular Epididymal Sperm Extraction (Micro-TESE) Surgical sperm retrieval technique for men with non-obstructive azoospermia using microscopic examination of testicular tissue, enabling use in ICSI/IVF.
• Percutaneous Epididymal Sperm Aspiration (PESA) Minimally invasive surgical procedure to retrieve sperm from the epididymis for men with obstructive azoospermia, used in conjunction with ICSI.
• Gender Selection / Family Balancing IVF-based service using PGT-A to help families achieve desired gender composition through embryo selection.
• Time-lapse Embryo Monitoring Advanced embryo culture system providing continuous monitoring of embryo development through imaging without disturbing incubation conditions, used as part of IVF cycles.
• Chromosomal Karyotyping Genetic analysis examining chromosomes to identify abnormalities that may affect fertility or cause hereditary conditions, offered to fertility patients.
• Sperm DNA Fragmentation Testing Diagnostic test assessing the integrity of sperm DNA, which impacts embryo development and IVF success rates, offered to couples and men undergoing fertility evaluation.
• Semen Analysis Comprehensive male fertility diagnostic test evaluating sperm count, motility, morphology, and other seminal parameters, offered to men undergoing fertility evaluation.
• Ovarian Reserve Testing Diagnostic assessment including AMH testing and antral follicle count to evaluate female egg quantity and fertility potential, offered to women undergoing fertility evaluation.
• Hysterosalpingogram (Tubal Assessment) Imaging test assessing fallopian tube patency and uterine cavity abnormalities for fertility evaluation, offered to women undergoing fertility workup.

Quantifiable outcome

• Middle East operations' bottom line quadrupling during Gulf Capital ownership period (2020-2025)
• +1 more outcomes

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Regional players

• Genea Biomedx: Australian fertility clinic group with proprietary time-lapse incubator technology (Geri); comparable on technology-led differentiation and mid-size multi-clinic platform structure.
• Moorfields Eye Hospital Abu Dhabi (UAE healthcare cluster): While not a fertility specialist, Moorfields anchors the same UAE premium-clinic real estate and international patient channels that ART relies on; provides a proxy for comparable GCC private-clinic unit economics and medical-tourist volumes.

Broad incumbents

• IVI RMA Global: The parent company and the world's largest assisted reproduction group; operates fertility clinics across Spain, Portugal, Italy, the Americas, and now the Middle East (via ART Fertility). Comparable on full ART service stack, genomics capabilities, and premium positioning.
• Cleveland Clinic Abu Dhabi: Multi-specialty US-affiliated hospital in the same Abu Dhabi flagship zone; competes for high-acuity international patients and sets the clinical-quality benchmark that premium fertility operators like ART must match.
• Mubadala Healthcare: UAE sovereign-backed healthcare platform operating premium hospitals and clinics (including Imperial College London Diabetes Centre, Cleveland Clinic Abu Dhabi partnership); competes for the same expat/medical-tourist premium patient segment.

Direct peers

• Fakih IVF: Direct GCC-region competitor founded by Dr. Michael Fakih, operating IVF clinics in UAE, Saudi Arabia, and other Middle East markets. Comparable on core IVF/ICSI services, male-factor treatments, and regional patient acquisition.
• HealthPlus Fertility: UAE-based fertility and reproductive health provider within the wider HealthPlus network; competes head-to-head with ART in Abu Dhabi and Dubai on IVF cycles, ICSI, and fertility preservation.
• Bourn Hall Fertility Centre: Historic UK IVF pioneer with international expansion into the Middle East; offers comparable full-stack ART services, strong brand heritage, and is a recognized benchmark for success-rate-led marketing.
• CCRM (Colorado Center for Reproductive Medicine): US fertility network known for proprietary genomics lab and high success rates; comparable on PGT-driven positioning, multi-site clinic model, and premium pricing strategy.
• NewHope Fertility Center: US fertility clinic brand with international patient program and advanced ART/IVM offerings; comparable on international patient acquisition, premium positioning, and technology-led marketing.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/art_fertility
• YouTubeyoutube.com/@art.fertility.clinics
• Facebookfacebook.com/artfertilityclinics
• LinkedInlinkedin.com/company/artfertilityclinics
• Instagraminstagram.com/art.fertility.clinics

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ART Fertility Clinics